Imaging Techniques for Breast Cancer Diagnosis

Imaging Techniques for Breast Cancer Diagnosis

Debasray Saha (Institute of Applied Medicines and Research, Ghaziabad, India), Neeraj Vaishnav (University of Rajasthan, India) and Abhimanyu Kumar Jha (Institute of Applied Medicines and Research, Ghaziabad, India)
Copyright: © 2021 |Pages: 23
DOI: 10.4018/978-1-7998-3456-4.ch009

Abstract

Breast cancer is the most typical variety of cancer in women worldwide. Mammography is the “gold standard” for the analysis of the breast from an imaging perspective. Altogether, the techniques used within the management of cancer in all stages are multiple biomedical imaging. Imaging as a very important part of cancer clinical protocols can offer a range of knowledge regarding morphology, structure, metabolism, and functions. Supported by relevant literature, this text provides an outline of the previous and new modalities employed in the sector of breast imaging. Any progress in technology can result in increased imaging speed to satisfy physiological processes necessities. One of the problems within the designation of breast cancer is sensitivity limitation. To overcome this limitation, complementary imaging examinations are used that historically include screening, ultrasound, MRI, etc.
Chapter Preview
Top

Introduction

Breast cancer is that the most ordinarily occurring cancer in women and therefore the second most typical cancer overall. There were over two million new cases in 2018. The highest twenty-five countries with the best rates of breast cancer in 2018 are given within Table 1 below (Bray F et al., 2019). BC ranks first among the cancers diagnosed in women between 20 and 59 years of age (Siegel R et al., 2012). During the past thirty years, BC mortality in Chinese females has followed a gradual upward trend, creating it the fifth most typical explanation for cancer death in females (Jia M et al., 2011). BC is also a massive financial load and source of pain in patients’ daily lives (Diaby V et al., 2015). The clinical outcome of BC is vastly variable, starting from complete characteristic to a time span of ten years post-surgical treatment, because of the heterogeneous cluster of tumors conferred with BC (Colombo PE et al., 2011; Pracella D et al., 2013). When breast cancer has grown to the point where physical signs and symptoms appear, the patient feels a breast lump (usually painless) (Iorio MV et al., 2011). Other shows embrace tenderness, skin irritation or dimpling, and nipple discharge or pain, scaliness, ulceration, or retraction. Breast pain typically because of benign conditions and not usually the primary symptom of breast carcinoma (Iorio MV et al., 2011).

Biomedical imaging techniques, one in all the most pillars of comprehensive cancer care, has several benefits as well as real time observation, accessibility while not tissue destruction, least or no invasiveness and would possibly operate over wide ranges of sometime and size scales involved in biological and pathological processes. Time scales go from milliseconds for super molecule binding and chemical reactions to years for diseases like cancer.

The recent role of imaging in cancer management is shown in Figure 1 and depends on screening and symptomatic unhealthiness management.

The upcoming role of imaging in cancer management is shown in Figure 2 and is bothered with pre-symptomatic, minimally invasive and targeted medical aid. Early diagnosing has been the most important think about the decrease of mortality and cancer management prices.

Table 1.
The top 25 countries with the highest rates of breast cancer in 2018.
978-1-7998-3456-4.ch009.g01
Figure 1.

The recent role of imaging in cancer management.

978-1-7998-3456-4.ch009.f01
Figure 2.

The upcoming role of imaging in cancer management.

978-1-7998-3456-4.ch009.f02
Top

Primary Evaluation & Stages

History

A thorough patient history is necessary for the physician to recognize danger factors for breast cancer. Some risk actors are well recognized, and others designate possible increased risk (Van Ongeval Ch et al.,2007, Newcomb PA et al.,2002, Weiss LK et al.,2002, Key TJ et al.,2003, Barton MB et al.,1999) (Tables 2 & 3).

Table 2.
Risk circumstances for Breast Cancer (BC)
978-1-7998-3456-4.ch009.g02
Table 3.
Compatible history with palpable breast masses in women.
978-1-7998-3456-4.ch009.g03

Complete Chapter List

Search this Book:
Reset